Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
3.000
-0.080 (-2.60%)
At close: Oct 26, 2026, 4:00 PM EDT
2.990
-0.010 (-0.33%)
After-hours: Oct 26, 2026, 7:55 PM EDT

Ardelyx Revenue

Ardelyx had revenue of $120.88M in the quarter ending June 30, 2026, with 23.77% growth. This brings the company's total for the last twelve months to $450.89M, up 16.77% year-over-year. In the year 2025, Ardelyx had annual revenue of $407.32M with 22.09% growth. That makes Ardelyx the 11,816th largest company in the world by revenue and 2,353rd in the United States.

Revenue (ttm)
$450.89M
Revenue Growth
+16.77%
P/S Ratio
1.66
Revenue / Employee
$922,074
Employees
489
Market Cap
747.56M

Revenue Chart

Revenue by Geography

  • United States 377.81M 92.8%
  • Asia Pacific 29.17M 7.2%
  • North America 342.00K 0.1%
Fiscal year ended Dec 31, 2025 See the full Ardelyx breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025407.32M73.71M22.09%
Dec 31, 2024333.62M209.16M168.06%
Dec 31, 2023124.46M72.30M138.61%
Dec 31, 202252.16M42.06M416.57%
Dec 31, 202110.10M2.53M33.36%
Dec 31, 20207.57M2.29M43.36%
Dec 31, 20195.28M2.67M102.57%
Dec 31, 20182.61M-39.39M-93.79%
Dec 31, 201742.00M--
Dec 31, 2016---
Dec 31, 201524.03M-7.60M-24.02%
Dec 31, 201431.62M2.70M9.32%
Dec 31, 201328.93M23.52M434.71%
Dec 31, 20125.41M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Pharming Group366.48M
Geron204.56M
Arbutus Biopharma181.72M
Apnimed115.12M
Kura Oncology77.23M
Inventiva2.81M
Revenue Rankings